LONG BEACH, California – Eybna, a global expertise firm specializing in hashish and botanical drugs, is proud to announce the launch of its Functional Line; which incorporates data-driven phytochemical formulations designed to satisfy essentially the most in-demand wellness wants: focus, sleep, nervousness, ache, irritation and temper administration.
The core expertise behind these formulations is the fruits of practically a decade of scientific analysis and organic information evaluation. Every formulation is made up of particular lively botanical compounds that work collectively to synergistically activate receptors throughout the physique’s endocannabinoid, GABAergic and serotonergic methods. This has resulted in a first-of-its-kind terpene-based shopper useful product line.
This primary launch contains 10 Receptor-SpecificTM terpene and cannabinoid proprietary formulations, amongst them:
- CB1™ Receptor-Particular Formulation: This formulation is designed to activate the CB1 central receptor within the Endocannabinoid system. The CB1 receptor is thought to be activated by Δ9-THC and related with ache reduction and sleep help.
CB2™ Receptor-Particular Formulation:
- This formulation is designed to activate the CB2 receptor within the Endocannabinoid system. The CB2 receptor is thought to be activated by CBD and related to anti-anxiety and anti inflammatory properties.
5-HT3™ Receptor-Particular Formulation:
- This formulation is designed to activate the 5-HT3 receptor within the Serotonergic system. The 5-HT3 receptor is thought to be activated by Psilocybin and related to cognitive capabilities comparable to focus, studying and reminiscence.
TRPV1™ Receptor-Particular Formulation:
This formulation is designed to activate the TRPV1 receptor within the Endocannabinoid system. The TRPV1 receptor is thought to be activated by CBD and Capsaicin. It’s related to irritation and ache notion.
All through the years of knowledge gathering from completely different sources, together with ethnobotanical big-data analysis, in vitro and in vivo research, and in silico computer-aided organic screening, Eybna has developed the world’s largest phytochemical database. This phytochemical database maps out the chemical and organic actions of 1000’s of compounds and tracks their interplay with the human physique’s receptors.
The top outcomes are unequalled, data-driven formulations permitting CPG and hashish manufacturers to engineer their very own customized wellness merchandise and obtain desired results in numerous product mediums–from inhalables, consumables to topicals and extra.
“Eybna is proud to satisfy the wants of lots of of hundreds of thousands of individuals worldwide to enhance their high quality of life by introducing a useful, pharmacological-active class of botanical merchandise. The pioneering expertise by Eybna makes use of a large set of essentially the most superior analysis instruments obtainable to science at present, aiming to make pure compounds safer and simpler than pharmaceutical artificial medication for chosen wellness wants,” stated Eybna CEO and Co-founder Nadav Eyal.
“By extracting the therapeutic advantages from pure compounds, like terpenes and cannabinoids, Eybna brings pharmacologically lively options in an easily-applicable formulation kind for indications comparable to sleep, ache and nervousness,” added Eyal. The brand new line of Receptor-Particular™ Formulations is a crucial milestone of Eybna’s steady efforts in the direction of predictable hashish consumption, broadening our scope from leisure to useful, touching the wants of many extra folks worldwide.”
Worldwide manufacturers within the CPG, wellness and hashish markets now have the chance to unlock new focused and particular experiences, all backed by science.
Along with rising its product choices within the U.S., earlier this yr Eybna launched NT-VRL®, a novel, patented, data-driven terpene formulation for which research demonstrated its potential to function an anti-inflammatory and antiviral preventative and remedy to human coronaviruses, as printed within the peer-reviewed journal Life.
Eybna will showcase their full line of merchandise together with the brand new Functional Line Receptor-SpecificTM formulations at MJBizCon in Las Vegas from October 20-22. The corporate will likely be exhibiting at MJBizCon North Corridor, Sales space #N2521.
For added data on Eybna, its merchandise, expertise, science and white papers, please go to www.eybna.com or contact Avichai Elbaz at [email protected].
About Eybna
Eybna is a pioneering expertise firm and terpene producer with US HQ places of work in California and R&D facilities in Israel and Colorado. With a forward-thinking Analysis & Improvement group, composed of extremely achieved Ph.D. scientists and engineers, Eybna researches the therapeutic advantages of hashish phytochemicals to advance the mission of enhancing the well being of mankind. Eybna’s intensive proprietary database of hashish phytochemicals, alongside partnerships with academia and main trade professionals, permit the corporate to constantly combine superior analysis within the strategy of product improvement, reworking precious scientific data into simply relevant merchandise that serve the wants and improve the experiences of shoppers worldwide. Join with us on www.eybna.com.
